DEDICATE DOUBLE-BLIND EVALUATION OF DAPAGLIFLOZIN ON THE INCIDENCE OF CARDIOVASCULAR-ASSOCIATED EVENTS - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
85525589
Word Mark
DEDICATE DOUBLE-BLIND EVALUATION OF DAPAGLIFLOZIN ON THE INCIDENCE OF CARDIOVASCULAR-ASSOCIATED EVENTS
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2012-12-14
Filing Date
2012-01-26
Mark Drawing
4000 - Standard character mark
Typeset
Attorney Name
Law Office Assigned Location Code
L30
Employee Name
RAPPAPORT, SETH A
Statements
Goods and Services
Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2012-01-30
Primary Code
042
Correspondences
Name
MARILYN F. KELLY
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2012-01-30 | NEW APPLICATION ENTERED IN TRAM |
| 2012-01-30 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2012-05-05 | ASSIGNED TO EXAMINER |
| 2012-05-18 | NON-FINAL ACTION WRITTEN |
| 2012-05-18 | NON-FINAL ACTION E-MAILED |
| 2012-05-18 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2012-07-10 | ASSIGNED TO EXAMINER |
| 2012-12-14 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 2012-12-14 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
